Institute of Neurology, Fondazione Policlinico Gemelli IRCCS, Rome, Italy.
Laboratory of Physiology and Pharmacology of Pain, IRCCS San Raffaele, Rome, Italy.
Neurol Sci. 2024 Oct;45(10):4741-4755. doi: 10.1007/s10072-024-07634-1. Epub 2024 Jun 10.
Phantom Limb Syndrome (PLS) can be defined as the disabling or painful sensation of the presence of a body part that is no longer present after its amputation. Anatomical changes involved in Phantom Limb Syndrome, occurring at peripheral, spinal and brain levels and include the formation of neuromas and scars, dorsal horn sensitization and plasticity, short-term and long-term modifications at molecular and topographical levels. The molecular reorganization processes of Phantom Limb Syndrome include NMDA receptors hyperactivation in the dorsal horn of the spinal column leading to inflammatory mechanisms both at a peripheral and central level. At the brain level, a central role has been recognized for sodium channels, BDNF and adenosine triphosphate receptors. In the paper we discuss current available pharmacological options with a final overview on non-pharmacological options in the pipeline.
幻肢综合征(PLS)可以定义为肢体截肢后仍然存在的身体部位的致残或疼痛感觉。幻肢综合征涉及到外周、脊髓和大脑水平的解剖学变化,包括神经瘤和疤痕的形成、背角敏化和可塑性、分子和地形水平的短期和长期改变。幻肢综合征的分子重组过程包括脊柱背角 NMDA 受体的过度激活,导致外周和中枢水平的炎症机制。在大脑水平上,钠离子通道、BDNF 和三磷酸腺苷受体被认为起着核心作用。在本文中,我们讨论了目前可用的药理学选择,并最终概述了正在研究中的非药理学选择。